Search Results - "Bae, SeungJin"

Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea by Choi, Inseon, Lee, Donghwan, Son, Kyung-Bok, Bae, SeungJin

“…Abstract Background Human papillomavirus (HPV) is associated with a significant public health burden, yet few studies have been conducted in Asia, especially…”
Get full text

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? by Kim, Yujeong, Kwon, Hye-Young, Godman, Brian, Moorkens, Evelien, Simoens, Steven, Bae, SeungJin

“…To compare the market dynamics of biosimilar infliximab among four Organization for Economic Cooperation and Development (OECD) countries (UK, France, Japan,…”
Get full text

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea by Bae, SeungJin, Lee, Joohee, Bae, Eun-Young

“…We aimed to describe the types of uncertainties examined in the economic evaluations submitted for reimbursement in Korea and their impact on the incremental…”
Get full text

Impact and challenges of enactment for advanced regenerative medicine in South Korea by Kim, Dong-Sook, Bae, SeungJin

“…The Korean government has enacted the Act on Advanced Regenerative Medicine and Advanced Biological products (ARMAB) in August 2019, and it has been…”
Get full text

Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea by Kim, Do Yeun, Ha, Hyerim, Bae, SeungJin, Kang, Jin-Hyoung

“…BACKGROUNDAs the role of immunotherapies and personalized medicine grow, cancer patients have faced many choices in treatments and have suffered financial…”
Get full text

Corporate social responsibility of pharmaceutical industry in Korea by Bae, Green, Ahn, Jeong-Hoon, Lim, Kyung-Min, Bae, SeungJin

“…Background: Global pharmaceutical companies in Korea argue that the development of innovative drugs should be recognized as a social contribution, yet it has…”
Get full text

How can we improve patients’ access to new drugs under uncertainties? : South Korea’s experience with risk sharing arrangements by Lee, Boram, Bae, Eun-Young, Bae, SeungJin, Choi, Hyun-Jin, Son, Kyung-Bok, Lee, Young-Sil, Jang, Suhyun, Lee, Tae-Jin

“…Abstract Background New drugs including cancer drugs and orphan drugs are becoming increasingly more expensive. Risk sharing arrangements (RSAs) could manage…”
Get full text

Relationship of ceramide–, and free fatty acid–cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins by Joo, Kyung-Mi, Hwang, Jee-Hyun, Bae, SeungJin, Nahm, Dong-Ho, Park, Hae-Sim, Ye, Young-Min, Lim, Kyung-Min

Get full text

Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate by Park, Jeewon, Bae, SeungJin, Lee, Tae-Jin, Son, Kyung-Bok

“…Understanding marketing strategies and price competition among manufacturers is essential to manage health care expenditures, particularly those related to…”
Get full text

Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement by Kim, Dong-Sook, Lee, Geunwoo, Cho, Hyungyung, Bae, SeungJin

“…Regenerative medicine (RM) has considerable potential to address the needs of aging-related and uncurable diseases. However, its incorporation into…”
Get full text

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future by Godman, Brian, Haque, Mainul, Leong, Trudy, Allocati, Eleonora, Kumar, Santosh, Islam, Salequl, Charan, Jaykaran, Akter, Farhana, Kurdi, Amanj, Vassalo, Carlos, Bakar, Muhammed Abu, Rahim, Sagir Abdur, Sultana, Nusrat, Deeba, Farzana, Khan, M. A. Halim, Alam, A. B. M. Muksudul, Jahan, Iffat, Kamal, Zubair Mahmood, Hasin, Humaira, Munzur-E-Murshid, Nahar, Shamsun, Haque, Monami, Dutta, Siddhartha, Abhayanand, Jha Pallavi, Kaur, Rimple Jeet, Rwegerera, Godfrey Mutashambara, Nascimento, Renata Cristina Rezende Macedo do, Dias Godói, Isabella Piassi, Irfan, Mohammed, Amu, Adefolarin A., Matowa, Patrick, Acolatse, Joseph, Incoom, Robert, Sefah, Israel Abebrese, Acharya, Jitendra, Opanga, Sylvia, Njeri, Lisper Wangeci, Kimonge, David, Kwon, Hye-Young, Bae, SeungJin, Khuan, Karen Koh Pek, Abubakar, Abdullahi Rabiu, Sani, Ibrahim Haruna, Khan, Tanveer Ahmed, Hussain, Shahzad, Saleem, Zikria, Malande, Oliver Ombeva, Piloya-Were, Thereza, Gambogi, Rosana, Hernandez Ortiz, Carla, Alutuli, Luke, Kalungia, Aubrey Chichonyi, Hoxha, Iris, Marković-Peković, Vanda, Tubic, Biljana, Petrova, Guenka, Tachkov, Konstantin, Laius, Ott, Harsanyi, András, Inotai, András, Jakupi, Arianit, Henkuzens, Svens, Garuoliene, Kristina, Gulbinovič, Jolanta, Wladysiuk, Magdalene, Rutkowski, Jakub, Mardare, Ileana, Fürst, Jurij, McTaggart, Stuart, MacBride-Stewart, Sean, Pontes, Caridad, Zara, Corinne, Tagoe, Eunice Twumwaa, Banzi, Rita, Wale, Janney, Jakovljevic, Mihajlo

“…Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global…”
Get full text

Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study by Bae, Seungjin, Shim, Ki-Nam, Kim, Nayoung, Kang, Jung Mook, Kim, Dong-Sook, Kim, Kyoung-Min, Cho, Yu Kyung, Jung, Sung Woo

“…Perforated peptic ulcer (PPU) is associated with serious health and economic outcomes. However, few studies have estimated the incidence and health outcomes of…”
Get full text

Analysis of Statistical Methods Currently used in Toxicology Journals by Na, Jihye, Yang, Hyeri, Bae, SeungJin, Lim, Kyung-Min

“…Statistical methods are frequently used in toxicology, yet it is not clear whether the methods employed by the studies are used consistently and conducted…”
Get full text

Mental Stress from Animal Experiments: a Survey with Korean Researchers by Kang, Minji, Han, AhRam, Kim, Da-eun, Seidle, Troy, Lim, Kyung-Min, Bae, SeungJin

“…Animal experiments have been widely conducted in the life sciences for more than a century, and have long been a subject of ethical and societal controversy…”
Get full text

Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy by Choi, Gyeyoung, Shin, Gyeongseon, Bae, SeungJin

“…Although chimeric antigen receptor (CAR) T-cell therapy has shown a high response rate in lymphoma patients, its cost-effectiveness is controversial due to the…”
Get full text

Analysis of Statistical Methods Currently used in Toxicology Journals by Na, Jihye, Yang, Hyeri, Bae, SeungJin, Lim, Kyung-Min

“…Statistical methods are frequently used in toxicology, yet it is not clear whether the methods employed by the studies are used consistently and conducted…”
Get full text

Impact of High Fat Diet-induced Obesity on the Plasma Levels of Monoamine Neurotransmitters in C57BL/6 Mice by Kim, Minjeong, Bae, SeungJin, Lim, Kyung-Min

“…Obesity is one of the most serious health problems in developed countries. It negatively affects diverse aspects of human wellbeing. Of these, a relationship…”
Get full text

Modeling Healthcare Costs Attributable to Secondhand Smoke Exposure at Home among South Korean Children by Park, Jeewon, Bae, SeungJin

“…Children exposed to secondhand smoke (SHS) are at increased risk for disease. We sought to estimate the medical costs among Korean children who were exposed to…”
Get full text

Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea by Choi, Gyeyoung, Kim, Yujeong, Shin, Gyeongseon, Bae, SeungJin

“…We sought to estimate the lifetime healthcare costs and outcomes associated with the exposure to the escalated concentration of fine particulate matter…”
Get full text

Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study by Shin, Gyeongseon, Kim, Byung Soo, Kim, Do Yeun, Bae, SeungJin

“…Introduction Biosimilars offer a cost-effective alternative to original biopharmaceuticals with comparable efficacy and safety. The perception and familiarity…”
Get full text